Evercore Wealth Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Sell
1,000
-786
-44% -$154K ﹤0.01% 393
2026
Q1
$350K Hold
1,786
0.01% 316
2025
Q4
$310K Hold
1,786
﹤0.01% 333
2025
Q3
$340K Sell
1,786
-19
-1% -$3.37K 0.01% 334
2025
Q2
$324K Hold
1,805
0.01% 335
2025
Q1
$305K Hold
1,805
﹤0.01% 336
2024
Q4
$272K Sell
1,805
-75
-4% -$11.7K ﹤0.01% 349
2024
Q3
$292K Hold
1,880
﹤0.01% 347
2024
Q2
$257K Hold
1,880
﹤0.01% 360
2024
Q1
$250K Sell
1,880
-19
-1% -$2.46K ﹤0.01% 370
2023
Q4
$262K Buy
+1,899
New +$250K ﹤0.01% 371
2021
Q1
Sell
-1,708
Closed -$204K 433
2020
Q4
$204K Buy
+1,708
New +$208K ﹤0.01% 412
2018
Q1
Sell
-100
Closed -$10K 453
2017
Q4
$10K Sell
100
-60
-38% -$5.69K ﹤0.01% 811
2017
Q3
$15K Hold
160
﹤0.01% 747
2017
Q2
$18K Hold
160
﹤0.01% 735
2017
Q1
$16K Sell
160
-13
-8% -$1.24K ﹤0.01% 782
2016
Q4
$16K Buy
173
+73
+73% +$6.29K ﹤0.01% 775
2016
Q3
$8K Hold
100
﹤0.01% 885
2016
Q2
$8K Hold
100
﹤0.01% 869
2016
Q1
$7K Hold
100
﹤0.01% 831
2015
Q4
$7K Hold
100
﹤0.01% 884
2015
Q3
$6K Hold
100
﹤0.01% 873
2015
Q2
$7K Hold
100
﹤0.01% 956
2015
Q1
$8K Hold
100
﹤0.01% 889
2014
Q4
$7K Hold
100
﹤0.01% 771
2014
Q3
$6K Sell
100
-48
-32% -$2.96K ﹤0.01% 856
2014
Q2
$9K Buy
+148
New +$8.67K ﹤0.01% 847

Other funds holding DGX

Evercore Wealth Management's DGX Position: Q2 2026 in Review

Evercore Wealth Management reduced its Quest Diagnostics (DGX) stake by 44% in Q2 2026, selling an estimated $154K and leaving 1,000 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #393.

Evercore Wealth Management first reported a position in DGX in Q2 2014 and has held it in 27 quarters since. The position peaked at $350K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Evercore Wealth Management held 1,000 shares of Quest Diagnostics worth $212K as of Q2 2026.
  • Evercore Wealth Management sold 786 Quest Diagnostics shares in Q2 2026, an estimated $154K.
  • Quest Diagnostics made up ﹤0.01% of Evercore Wealth Management's portfolio in Q2 2026, its #393 holding.
  • Evercore Wealth Management first reported a position in Quest Diagnostics in Q2 2014 and has held it in 27 quarters since.
  • Evercore Wealth Management's Quest Diagnostics position peaked at $350K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.